Quarterly report pursuant to Section 13 or 15(d)

Accounts Payable, Accrued Liabilities and Other

v3.7.0.1
Accounts Payable, Accrued Liabilities and Other
3 Months Ended
Mar. 31, 2017
Accounts Payable and Accrued Liabilities [Abstract]  
Accounts Payable, Accrued Liabilities and Other

Accounts payable at March 31, 2017 and December 31, 2016 includes an aggregate of $81,000 and $116,000, respectively, due to related parties related to director fees and MT scientific advisory board fees. At March 31, 2017, approximately $990,000 of accounts payable is being disputed by the Company related to unauthorized expenditures by a former executive and related legal fees incurred during the year ended December 31, 2016.

 

Accrued liabilities and other at March 31, 2017 and December 31, 2016 includes an aggregate of $362,000 and $106,000, respectively, due to related parties related to executive bonuses, director fees, deferred salary owed to Dr. Goldberg, and MT scientific advisory board fees.